-
FDA Clears Covid-19 Nasal Spray/Drops Vaccine Trial
A company developing vaccines delivered through the nose received FDA clearance to begin a clinical trial of its vaccine protecting against Covid-19 infections.
-
DNA Storage Company Gains $24M in New Funds
A maker of high-density chip devices storing data with nucleic acids similar to DNA is raising $24 million in its second venture financing round.
-
Molecular Diagnostics Company Acquired in $1.8B Deal
GenMark Diagnostics, a developer of diagnostics systems using genomic analysis, was acquired by drug maker Roche in a deal valued at $1.8 billion.
-
Biotech Manufacturer Gains $525M in New Funds
A company providing specialized lab and manufacturing services for cell and gene therapy developers is raising $525 million in its third venture funding round.
-
Infographic – Steady Growth for mRNA Trials
The pandemic has demonstrated messenger RNA’s recognized potential for vaccines and treatments that induce an immune response.
-
Smart Walking System Wins Multiple Sclerosis Challenge
A company developing systems to assist with walking is the winner of a competition for innovations to help people with multiple sclerosis.
-
New Covid-19 mRNA Vaccine Trial Begins
A clinical trial is underway testing a new Covid-19 vaccine based on messenger RNA, developed by biotech company Translate Bio and drug maker Sanofi.
-
Finding Your Business Opportunity Overseas
Looking overseas is one of the best opportunities you might have to take a business to where a market is ready and waiting for it.
-
Trial Tests Microbiome Effect on Covid-19 Vaccines
A clinical trial is underway assessing the impact of gut microbes on immune responses generated by vaccines protecting against Covid-19 disease.
-
In-Body Gene Editing Tested as Sickle Cell Treatment
Tests with lab mice show the feasibility of editing genes in blood-forming stem cells in bone marrow as a potential treatment for sickle cell disease.